The Pharmacology of Radiolabeled Cationic Antimicrobial Peptides

Journal of Pharmaceutical Sciences - Tập 97 - Trang 1633-1651 - 2008
Carlo P.J.M. Brouwer1, Marty Wulferink1, Mick M. Welling2
1AM-Pharma, Bunnik, The Netherlands
2Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center (LUMC), Leiden, The Netherlands

Tài liệu tham khảo

Hancock, 1997, Peptide antibiotics, Lancet, 349, 418, 10.1016/S0140-6736(97)80051-7 Mcphee, 2005, Function and therapeutic potential of host defence peptides, J Peptide Sci, 11, 677, 10.1002/psc.704 Martin, 1995, Defensins and other endogenous peptide antibiotics of vertebrates, J Leukoc Biol, 58, 128, 10.1002/jlb.58.2.128 Hancock, 2000, The role of antimicrobial peptides in animal defenses, Proc Natl Acad Sci USA, 97, 8856, 10.1073/pnas.97.16.8856 Yang, 2001, The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity, Cell Mol Life Sci, 58, 978, 10.1007/PL00000914 Otvos, 2005, Antibacterial peptides and proteins with multiple cellular targets, J Peptide Sci, 11, 697, 10.1002/psc.698 Ginsburg, 2002, The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae, APMIS, 110, 753, 10.1034/j.1600-0463.2002.1101101.x Brogden, 2005, Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?, Nat Rev Microbiol, 3, 238, 10.1038/nrmicro1098 Welling, 1998, Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation, J Clin Invest, 102, 1583, 10.1172/JCI3664 Cole, 2002, Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1, Proc Natl Acad Sci USA, 99, 1813, 10.1073/pnas.052706399 Lupetti, 2000, Candidacidal activities of human lactoferrin peptides derived from the N terminus, Antimicrob Agents Chemother, 44, 3257, 10.1128/AAC.44.12.3257-3263.2000 Nibbering, 2001, Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria, Infect Immun, 69, 1469, 10.1128/IAI.69.3.1469-1476.2001 Sharma, 2001, Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis, Antimicrob Agents Chemother, 45, 639, 10.1128/AAC.45.2.639-640.2001 Brouwer, 2006, Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice, Peptides, 27, 2585, 10.1016/j.peptides.2006.05.022 Cornish, 2004, Lactoferrin is a potent regulator of bone cell activity and increases bone, formation in vivo, Endocrinology, 145, 4366, 10.1210/en.2003-1307 Steinstraesser, 2006, The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers, Ann Plas Surg, 56, 93, 10.1097/01.sap.0000190883.30005.91 Peschel, 2002, How do bacteria resist human antimicrobial peptides?, Trends Microbiol, 10, 179, 10.1016/S0966-842X(02)02333-8 Bishop, 2006, Friend or foe? Antimicrobial peptides trigger pathogen virulence, Trends Mol Med, 12, 3, 10.1016/j.molmed.2005.11.001 Jin, 2004, Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism, J Immunol, 172, 1169, 10.4049/jimmunol.172.2.1169 Singh, 2000, Synergistic and additive killing by antimicrobial factors found in human airway surface liquid, Am J Physiol Lung C, 279, L799, 10.1152/ajplung.2000.279.5.L799 Porro, 2001, Direct and indirect bacterial killing functions of neutrophil defensins in lung explants, Am J Physiol Lung C, 281, L1240, 10.1152/ajplung.2001.281.5.L1240 Lupetti, 2003, Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species, Antimicrob Agents Chemother, 47, 262, 10.1128/AAC.47.1.262-267.2003 Hwang, 2001, A simple method for the purification of an antimicrobial peptide in recombinant Escherichia coli, Mol Biotechnol, 18, 193, 10.1385/MB:18:3:193 van Berkel, 2002, Large scale production of recombinant human lactoferrin in the milk of transgenic cows, Nat Biotechnol, 20, 484, 10.1038/nbt0502-484 Dawson, 2000, Chemical synthesis, characterization and activity of RK-1, a novel alpha-defensin-related peptide, J Peptide Sci, 6, 19, 10.1002/(SICI)1099-1387(200001)6:1<19::AID-PSC230>3.0.CO;2-1 de Koster, 1995, The use of dedicated peptide libraries permits the discovery of high affinity binding peptides, J Immunol Methods, 187, 179, 10.1016/0022-1759(95)00182-A Zijlstra, 2006, Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with pet, Appl Radiat Isotopes, 64, 802, 10.1016/j.apradiso.2006.02.095 Honigman, 2001, Imaging transgene expression in live animals, Mol Ther, 4, 239, 10.1006/mthe.2001.0437 Jurisson, 1999, Potential technetium small molecule radiopharmaceuticals, Chem Rev, 99, 2205, 10.1021/cr980435t Anderson, 1999, Radiometal labeled agents (non-technetium) for diagnostic imaging, Chem Rev, 99, 2219, 10.1021/cr980451q Liu, 1999, Tc-99m-Labeled small peptides as diagnostic radiopharmaceuticals, Chem Rev, 99, 2235, 10.1021/cr980436l Sutcliffe-Goulden, 2002, Rapid solid phase synthesis and biodistribution of F-18-labelled linear peptides, Eur J Nucl Med Mol I, 29, 754, 10.1007/s00259-001-0756-3 Welling, 2002, Radiochemical and biological characteristics of 99mTc-UBI 29-41for imaging of bacterial infections, Nucl Med Biol, 29, 413, 10.1016/S0969-8051(02)00292-5 Okarvi, 1999, Recent developments in Tc-99(m)-labelled peptide-based radiopharmaceuticals: An overview, Nucl Med Commun, 20, 1093, 10.1097/00006231-199912000-00002 Lupetti, 2003, Radiolabelled antimicrobial peptides for infection detection, Lancet Infect Dis, 3, 223, 10.1016/S1473-3099(03)00579-6 Fritzberg, 1992, Targeted proteins for diagnostic imaging: Does chemistry make a difference?, J Nucl Med, 33, 394 Pauwels, 1993, The labeling of proteins and LDL with 99mTc: A new direct method employing KBH4 and stannous chloride, Nucl Med Biol, 20, 825, 10.1016/0969-8051(93)90148-N Qu, 2001, Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm, Nucl Med Commun, 22, 203, 10.1097/00006231-200102000-00013 Decristoforo, 2002, The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides, Q J Nucl Med, 46, 195 Ballinger, 2002, The influence of carrier on 99mTc radiopharmaceuticals, Q J Nucl Med, 46, 224 Gariepy, 2002, A simple two-step approach for introducing a protected diaminedithiol chelator during solid-phase assembly of peptides, Bioconjugate Chem, 13, 679, 10.1021/bc0100814 Babich, 1993, Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection, J Nucl Med, 34, 1964 Welling, 2004, Infection detection in mice using Tc-99m-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41, Nucl Med Biol, 31, 503, 10.1016/j.nucmedbio.2003.11.009 Rossin, 2001, 99mTc-labeling experiments on CCK(4) by a direct method, Nucl Med Biol, 28, 865, 10.1016/S0969-8051(01)00254-2 Melendez-Alafort, 2003, Lys and Arg in UBI: A specific site for a stable Tc-99m complex?, Nucl Med Biol, 30, 605, 10.1016/S0969-8051(03)00055-6 Ferro-Flores, 2004, Molecular recognition and stability of Tc-99m-UBI 29-41based on experimental and semiempirical results, Appl Radiat Isotopes, 61, 1261, 10.1016/j.apradiso.2004.03.115 Welling, 2000, Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations, Eur J Nucl Med, 27, 292, 10.1007/s002590050036 Hiemstra, 1999, Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages, J Leukoc Biol, 66, 423, 10.1002/jlb.66.3.423 Garnier, 1978, Analysis of accuracy and implications of simple methods for predicting secondary structure of globular proteins, J Mol Biol, 120, 97, 10.1016/0022-2836(78)90297-8 Chou, 1974, Conformational parameters for amino-acids in helical, beta-sheet, and random coil regions calculated from proteins, Biochemistry, 13, 211, 10.1021/bi00699a001 Welling, 2001, 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections, J Nucl Med, 42, 788 Lupetti, 2002, Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections, Eur J Nucl Med Mol Imag, 29, 674, 10.1007/s00259-001-0760-7 Melendez-Alafort, 2004, Biokinetics of Tc-99m-UBI 29-41in humans, Nucl Med Biol, 31, 373, 10.1016/j.nucmedbio.2003.10.005 Akhtar, 2005, Antimicrobial peptide Tc-99m-ubiquicidin 29-41as human infection-imaging agent: Clinical trial, J Nucl Med, 46, 567 Ferro-Flores, 2003, In vitro and in vivo assessment of Tc-99m-UBI specificity for bacteria, Nucl Med Biol, 30, 597, 10.1016/S0969-8051(03)00054-4 Saeed, 2004, Tc-99m-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection, J Nucl Med, 45, 849 Nibbering, 2004, Tc-99m-labeled UBI 29-41peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus, J Nucl Med, 45, 321 Ferro-Flores, 2005, Kit for instant Tc-99m labeling of the antimicrobial peptide ubiquicidin 29-41, J Radioanal Nucl Chem, 266, 307, 10.1007/s10967-005-0908-1 Welling, 2005, Kit with technetium-99m labelled antimicrobial peptide UBI 29-41for specific infection detection, J Labelled Compd Rad, 48, 683, 10.1002/jlcr.961 Lupetti, 2003, Radiopharmaceuticals: New antimicrobial agents, Trends Biotechnol, 21, 70, 10.1016/S0167-7799(02)00032-X Farnaud, 2003, Lactoferrin-A multifunctional protein with antimicrobial properties, Mol Immunol, 40, 395, 10.1016/S0161-5890(03)00152-4 Mazurier, 1989, Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral-blood lymphocytes-Isolation of the receptors by antiligand-affinity chromatography, Eur J Biochem, 179, 481, 10.1111/j.1432-1033.1989.tb14578.x Nishiya, 1982, Contrasting effects of lactoferrin on human-lymphocyte and monocyte natural-killer activity and antibody-dependent cell-mediated cyto-toxicity, J Immunol, 129, 2519, 10.4049/jimmunol.129.6.2519 Shinoda, 1996, Effects of lactoferrin and lactoferricin(R) on the release of interleukin 8 from human polymorphonuclear leukocytes, Biosci Biotech Bioch, 60, 521, 10.1271/bbb.60.521 Gahr M, Speer CP, Damerau B, Sawatzki G.Influence of lactoferrin on the function of humanpolymorphonuclear leukocytes and monocytes.J Leukoc Biol 49:427-433. Lima, 1985, Lactoferrin effects on phagocytic cell-function 0.1. Increased uptake and killing of an intracellular parasite by murine macrophages and human-monocytes, J Immunol, 134, 4176, 10.4049/jimmunol.134.6.4176 Spik, 1982, Characterization and properties of the human and bovine lactotransferrins extracted from the feces of newborn-infants, Acta Paediatrica Scandinavica, 71, 979, 10.1111/j.1651-2227.1982.tb09560.x Borel Y,Fritsche R,Borel H,Dahlgren U,DalhmanHoglund A,Hanson LA.1996.Parenteral and oral administration of tolerogens: Protein-IgG conjugates. Miller, 1999, Allergy to bovine beta-lactoglobulin: Specificity of immunoglobulin E generated in the Brown Norway rat to tryptic and synthetic peptides, Clin Exp Allergy, 29, 1696, 10.1046/j.1365-2222.1999.00712.x Lee, 2005, Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice, J Med Microbiol, 54, 1049, 10.1099/jmm.0.45918-0 Dial, 2000, Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice, J Pharm Pharmacol, 52, 1541, 10.1211/0022357001777595 Troost, 2003, Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers, Eur J Clin Nutr, 57, 1579, 10.1038/sj.ejcn.1601727 Perry, 1998, Immunology of the tonsils, Immunol Today, 19, 414, 10.1016/S0167-5699(98)01307-3 Zhang, 1999, Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide, Infect Immun, 67, 1353, 10.1128/IAI.67.3.1353-1358.1999 Lupetti, 2003, Molecular targeted treatments for fungal infections: The role of drug combinations, Trends Mol Med, 9, 269, 10.1016/S1471-4914(03)00091-1 Yeaman, 2003, Mechanisms of antimicrobial peptide action and resistance, Pharmacol Rev, 55, 27, 10.1124/pr.55.1.2 Welling, 1999, Imaging of bacterial infections with Tc-99m-labeled human neutrophil peptide-1, J Nucl Med, 40, 2073 Oppenheim, 1988, Histatins, a novel family of histidine-rich proteins in human-parotid secretion-Isolation, characterization, primary structure, and fungistatic effects on Candida-Albicans, J Biol Chem, 263, 7472, 10.1016/S0021-9258(18)68522-9 Raj, 1990, Salivary histatin-5-Dependence of sequence, chain-length, and helical conformation for candidacidal activity, J Biol Chem, 265, 3898, 10.1016/S0021-9258(19)39678-4 Troxler, 1990, Structural relationship between human salivary histatins, J Dent Res, 69, 2, 10.1177/00220345900690010101 Groenink, 2003, Degradation of antimicrobial histatin-variant peptides in Staphylococcus aureus and Streptococcus mutans, J Dent Res, 82, 753, 10.1177/154405910308200918 Helmerhorst, 1997, Synthetic histatin analogues with broad-spectrum antimicrobial activity, Biochem J, 326, 39, 10.1042/bj3260039 Perezpaya, 1995, The role of amphipathicity in the folding, self-association and biological-activity of multiple subunit small proteins, J Biol Chem, 270, 1048, 10.1074/jbc.270.3.1048 Shai, 1999, Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides, BBA Biomembranes, 1462, 55, 10.1016/S0005-2736(99)00200-X Rothstein, 2002, Histatin-derived peptides: Potential agents to treat localised infections, Expert Opin Emerg Drugs, 7, 47, 10.1517/14728214.7.1.47 Zasloff, 2002, Antimicrobial peptides of multicellular organisms, Nature, 415, 389, 10.1038/415389a